表观遗传学
癌症表观遗传学
DNA甲基化
染色质
癌症研究
组蛋白脱乙酰基酶
组蛋白
生物
DNA甲基转移酶
表观遗传疗法
甲基转移酶
表观遗传学
计算生物学
DNA
组蛋白甲基转移酶
基因
基因表达
遗传学
甲基化
作者
Pan Wang,Hongwei Zhao,Fan Ren,Qingchun Zhao,Rui Shi,Xingyu Liu,Jinghao Liu,Yongwen Li,Ying Liu,Hongyu Liu,Jun Chen
出处
期刊:PubMed
日期:2020-02-20
卷期号:23 (2): 91-100
被引量:2
标识
DOI:10.3779/j.issn.1009-3419.2020.02.04
摘要
Epigenetic modification is closely related to the occurrence and development of tumors. It mainly regulates gene function and expression level through DNA methylation, histone modification, regulation of non-coding RNA and chromatin structure reconstruction. At present, epigenetic drugs have been gradually applied to the treatment of malignant tumors. Common drug types include: DNA methyltransferase inhibitors and histone deacetylase inhibitors. However, these drugs still have many shortcomings and a wide range of clinical applications need further research. Encouragingly, the epigenetic drugs in combination with various anti-tumor drugs have shown great application potential. In this paper, we summarized the development mechanism of epigenetics in malignant tumors and the progress of related drugs.【中文题目:表观遗传学在恶性肿瘤发生发展和治疗中的新进展】 【中文摘要:表观遗传学修饰与肿瘤的发生发展密切相关,其主要通过DNA甲基化、组蛋白修饰、非编码RNA调控和染色质结构重构等方式对基因功能和表达水平进行调控,从而影响肿瘤的进展。目前针对表观遗传学的药物已经逐渐应用于恶性肿瘤的治疗,常见的药物类型包括DNA甲基转移酶抑制剂和组蛋白去乙酰化酶抑制剂,但此类药物仍存在诸多不足之处广泛的临床应用仍需要进一步的研究,令人鼓舞的是表观遗传药物与多种抗肿瘤药物联合应用已表现出巨大的应用潜力。本文就表观遗传学在恶性肿瘤的发生发展机制和相关药物的新进展进行了综述。】 【中文关键词:肿瘤;表观遗传学;表观遗传治疗;联合用药】.
科研通智能强力驱动
Strongly Powered by AbleSci AI